Effect of Gunjaadi taila and Kantakaari taila in treatment of Dandruf

A Randomized Comparative Clinical study to assess the safety and efficacy of Gunjaadi Taila and Kantakaari Taila in the patients of Daarunaka with special reference to Dandruff

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/04/033249

Enrollment

Registered

2021-04-29

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

Intervention1: Gunjaadi taila Kantakaari taila tila taila: Group A- Dose: Gunjaadi taila as required for application (10-15 ml),twice in a week Duration: treatment period for 6 weeks

follow up 2 weeks Route of administration: Local application on scalp and gentle massage for 5-10 min. Group B- Dose- Kantakaari taila as required for application(10-15 ml),twice in a week Duratio

follow up 2 weeks Route of administration: Local application on scalp and gentle massage for 5-10 min. Intervention2: 1 Gunjaadi taila 2 Kantakaari taila: Group A- â?¢ Dose: Gunjaadi taila as requ

follow up 2 weeks â?¢ Route of administration: Local application on scalp and gentle massage for 5-10 min. Group B- â?¢ Dose- Kantakaari taila as required for application(10-15 ml),twice in a week â?

follow up 2 weeks â?¢ Route of administration: Local application on scalp and gentle massage for 5-10 min. Group Câ?? â?¢ Dose- Tila Taila as required for application (10-15 ml),twice in a week â?¢

follow up 2 weeks â?¢ Route o Control Intervention1: Tila taila: Dose - Taila taila as required for application (10-15 ml)twice in a week. Duration -treatment peroid for 6 week:follow up Route of admi

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patients of irrespective gender & socio economic status Patients between age group of 18-60 years Patients with symptoms of Daarunaka(Dandruff). Known cases of Daarunaka (Dandruff) who are willing to participate to study.

Exclusion criteria

Exclusion criteria: Exclusion criteria: Any reaction shown after application of trial drug. Patients with clinically significant systematic disease eg. Immunological deficiency, AIDS, current malignanicies, uncontrolled diabetes mellitus etc. Other scalp disorders like Psoriasis, Tineacapitis etc. Pregnant and lactating woman Systemic treatment with corticosteroids, antibiotics, immunosuppressantsetc , or topical treatments applied to the scalp within 7 days before inclusion in the study and that could interfere with the results of the study like ketoconazole, antidandruff shampoo etc.

Design outcomes

Primary

Measure	Time frame
change in ASFS(Adherent scalp flaking score) change in Score of pruritesTimepoint: 6 weeks	—

Secondary

Measure	Time frame
improvement in itching ,white scaly like structure ,dryness in scalpTimepoint: 6 weeks follow up 2 weeks	—

Countries

India

Contacts

Public ContactDr Shweta Kumari Yadav

national institute of ayurveda jaipur rajasthan 302002

sumitnathani2@rediff.com7665809886

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026